Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study. (Q38875343)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

title

Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

9

Robin Wood

1 reference

7 September 2017

12

Mark Hatherill

1 reference

28215501

7 September 2017

Willem Albert Hanekom

8

object named as

Willem A Hanekom

2 references

28215501

7 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

11

Thomas J Scriba

1 reference

7 September 2017

10

Helen McShane

1 reference

7 September 2017

Jason R Andrews

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Elisa Nemes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Michele Tameris

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Bernard S Landry

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Hassan Mahomed

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

J Bruce McClain

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Helen A Fletcher

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Robin Wood

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Helen McShane

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Thomas J Scriba

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Mark Hatherill

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

publication date

16 February 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

The Lancet. Respiratory medicine

3 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

282-290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

Tuberculosis vaccines and prevention of infection

3 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Clinical Case Definitions for Classification of Intrathoracic Tuberculosis in Children: An Update.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Influence of age and nutritional status on the performance of the tuberculin skin test and QuantiFERON-TB gold in-tube in young children evaluated for tuberculosis in Southern India

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Role of the QuantiFERON®-TB Gold In-Tube test in the diagnosis of intrathoracic childhood tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Tuberculin skin test and QuantiFERON® assay in young children investigated for tuberculosis in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

The sensitivity of an interferon-γ release assay in microbiologically confirmed pediatric tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

No added value of interferon-γ release to a prediction model for childhood tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected Children

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Serial interferon-γ release assay in children with latent tuberculosis infection and children with tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Evaluation of the prognostic value of IFN-gamma release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Negative and Positive Predictive Value of a Whole-Blood Interferon-γ Release Assay for Developing Active Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

How can we achieve better prevention of progression to tuberculosis among contacts?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Single-step QuantiFERON screening of adult contacts: a prospective cohort study of tuberculosis risk.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Whole blood interferon-γ release assay is a useful tool for the diagnosis of tuberculosis infection particularly among Bacille Calmette Guèrin-vaccinated children

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

QuantiFERON®-TB gold in-tube performance for diagnosing active tuberculosis in children and adults in a high burden setting

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Agreement between QuantiFERON®-TB Gold In-Tube and the tuberculin skin test and predictors of positive test results in Warao Amerindian pediatric tuberculosis contacts

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Interferon-gamma release assay sensitivity in children younger than 5 years is insufficient to replace the use of tuberculin skin test in western countries.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Performance of interferon-γ release assay for the diagnosis of active or latent tuberculosis in children in the first 2 years of age: a multicenter study of the Italian Society of Pediatric Infectious Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Extremes of age are associated with indeterminate QuantiFERON-TB gold assay results

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

The effect of age on whole blood interferon-gamma release assay response among children investigated for latent tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

A blood RNA signature for tuberculosis disease risk: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Serial testing of health care workers for tuberculosis using interferon-gamma assay

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Longitudinal analysis of QuantiFERON-TB Gold In-Tube in children with adult household tuberculosis contact in South Africa: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Transmission of tuberculosis in a South African community with a high prevalence of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930060-7

7 January 2021

The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28215501

12 December 2020

inferred from PubMed ID database lookup

Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28215501

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/S2213-2600(17)30060-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215501%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

28215501

1 reference